Back

KSF investigates AtaiBeckley’s proposed sale to Eli Lilly for $6.75 plus CVR

Verifying
  • KSF is investigating AtaiBeckley’s proposed sale to Eli Lilly.
  • $6.75 per share in cash would accompany up to $2.50 per share through a CVR.
  • KSF lists email, phone, and website contact options for shareholders.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
KSF investigates AtaiBeckley’s proposed sale to Eli Lilly for $6.75 plus CVR - CoinPost Terminal